Kim JW - Search Results

1

A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.

Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. Abramson DH, et al. Among authors: kim jw. Ophthalmology. 2008 Aug;115(8):1398-404, 1404.e1. doi: 10.1016/j.ophtha.2007.12.014. Epub 2008 Mar 14. Ophthalmology. 2008. PMID: 18342944 Clinical Trial.

2

Current management strategies for intraocular retinoblastoma.

Kim JW, Abramson DH, Dunkel IJ. Kim JW, et al. Drugs. 2007;67(15):2173-85. doi: 10.2165/00003495-200767150-00005. Drugs. 2007. PMID: 17927283 Review.

3

Fibrin sealant for retinoblastoma: where are we?

Martin NE, Kim JW, Abramson DH. Martin NE, et al. Among authors: kim jw. J Ocul Pharmacol Ther. 2008 Oct;24(5):433-8. doi: 10.1089/jop.2007.0110. J Ocul Pharmacol Ther. 2008. PMID: 18788992 Review.

4

Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma.

Brodie SE, Pierre Gobin Y, Dunkel IJ, Kim JW, Abramson DH. Brodie SE, et al. Among authors: kim jw. Doc Ophthalmol. 2009 Aug;119(1):13-22. doi: 10.1007/s10633-008-9164-3. Epub 2009 Jan 25. Doc Ophthalmol. 2009. PMID: 19169884

5

Published international classification of retinoblastoma (ICRB) definitions contain inconsistencies--an analysis of impact.

Novetsky DE, Abramson DH, Kim JW, Dunkel IJ. Novetsky DE, et al. Among authors: kim jw. Ophthalmic Genet. 2009 Mar;30(1):40-4. doi: 10.1080/13816810802452168. Ophthalmic Genet. 2009. PMID: 19172510

6

Topical treatment options for conjunctival neoplasms.

Kim JW, Abramson DH. Kim JW, et al. Clin Ophthalmol. 2008 Sep;2(3):503-15. doi: 10.2147/opth.s1606. Clin Ophthalmol. 2008. PMID: 19668748 Free PMC article.

7

Factors predictive of long-term visual outcomes of Group D eyes treated with chemoreduction and low-dose IMRT salvage: the Children's Hospital Los Angeles experience.

Berry JL, Jubran R, Wong K, Lee TC, Murphree AL, Kim JW. Berry JL, et al. Among authors: kim jw. Br J Ophthalmol. 2014 Aug;98(8):1061-5. doi: 10.1136/bjophthalmol-2013-304411. Epub 2014 Mar 26. Br J Ophthalmol. 2014. PMID: 24671926

8

Retcam fluorescein angiography findings in eyes with advanced retinoblastoma.

Kim JW, Ngai LK, Sadda S, Murakami Y, Lee DK, Murphree AL. Kim JW, et al. Br J Ophthalmol. 2014 Dec;98(12):1666-71. doi: 10.1136/bjophthalmol-2014-305180. Epub 2014 Jul 22. Br J Ophthalmol. 2014. PMID: 25053763

9

Patterns of subretinal fluid resolution in Group D eyes treated with chemoreduction: Experience from the Children's Hospital Los Angeles/University of Southern California.

Berry JL, Shih G, Moysidis SN, Jubran R, Wong K, Lee TC, Murphree AL, Kim JW. Berry JL, et al. Among authors: kim jw. Ophthalmic Genet. 2016 Dec;37(4):400-403. doi: 10.3109/13816810.2015.1115881. Epub 2016 Mar 2. Ophthalmic Genet. 2016. PMID: 26934665

10

Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.

Berry JL, Kogachi K, Aziz HA, McGovern K, Zolfaghari E, Murphree AL, Jubran R, Kim JW. Berry JL, et al. Among authors: kim jw. Pediatr Blood Cancer. 2017 Apr;64(4):10.1002/pbc.26270. doi: 10.1002/pbc.26270. Epub 2016 Nov 5. Pediatr Blood Cancer. 2017. PMID: 28221729 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results